NEW YORK ( TheStreet) -- Shares of Dynavax Technologies Corporation (Nasdaq: DVAX) were gapping down Wednesday morning with an open price 18.5% lower than Tuesday's closing price. The stock closed at $5.09 Tuesday and opened today's trading at $4.15.

The average volume for Dynavax has been 1.6 million shares per day over the past 30 days. Dynavax has a market cap of $750.5 million and is part of the health care sector and drugs industry. Shares are up 53.3% year to date as of the close of trading on Tuesday.

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases.

TheStreet Ratings rates Dynavax as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. You can view the full Dynavax Ratings Report.

Get more investment ideas from our investment research center.

null
MarketsStocks
Do You Understand
Your Portfolio?

TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.

Start Learning
Do You Know The 4 Pillars of Money Management?

TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.

Learn More
secure your
financial future

TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.

Start Learning
Get the Investing Edge.
Join Jim Cramer's Members-Only Investing Club
Become an Action Alerts PLUS member to learn from the pros how to invest wisely and build a customized portolio of blue chip stocks.
LEARN MORE
Uncover New Investment Opportunities With Our Team of Experts
Jim Cramer and his army of Wall Street pros serve up new trading ideas and in-depth market analysis every day.
LEARN MORE